AURKB and adrenal cortex carcinoma: Borges et al. observed more aggressive disease in tumors with overexpression of AURKA and AURKB and presumed that the inhibition of these proteins could be a promising approach for the treatment for ACC [26] by using Aurora-specific degraders [138].